AMIDATE Drug Patent Profile
✉ Email this page to a colleague
When do Amidate patents expire, and when can generic versions of Amidate launch?
Amidate is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in AMIDATE is etomidate. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the etomidate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amidate
A generic version of AMIDATE was approved as etomidate by HIKMA on November 4th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMIDATE?
- What are the global sales for AMIDATE?
- What is Average Wholesale Price for AMIDATE?
Summary for AMIDATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 161 |
| Clinical Trials: | 5 |
| Patent Applications: | 3,217 |
| Drug Prices: | Drug price information for AMIDATE |
| What excipients (inactive ingredients) are in AMIDATE? | AMIDATE excipients list |
| DailyMed Link: | AMIDATE at DailyMed |
Recent Clinical Trials for AMIDATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| South East Area Health Education Center, Wilmington, NC | Phase 4 |
| New Hanover Regional Medical Center | Phase 4 |
| University of California, Davis | Phase 4 |
Pharmacology for AMIDATE
| Drug Class | General Anesthetic |
| Physiological Effect | General Anesthesia |
US Patents and Regulatory Information for AMIDATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | AMIDATE | etomidate | INJECTABLE;INJECTION | 018227-001 | Sep 7, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
